Images List Premium Download Classic

Gastrointestinal

Gastrointestinal-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Novel aspirin derivatives and uses thereof
North Carolina Agricultural And Technical State University
November 09, 2017 - N°20170320810

The present invention provides novel aspirin derivatives useful for preventing and/or treating cancer. The novel compounds of this invention may be particularly useful for the prevention and/or treatment of cancers affecting the gastrointestinal system, such as colorectal cancer.
Conditional gastrointestinal stimulation for improved motility
Enterastim, Inc.
November 09, 2017 - N°20170319848

Systems and methods for gastrointestinal electrical stimulation to treat abnormalities in gastrointestinal motility are provided. In some embodiments, a system for relieving ileus includes an intraluminal catheter comprising: a catheter body having a proximal tip and a distal tip and a duodenal portion proximal to the distal tip of the catheter; and at least one electrode pair disposed along the ...
Gastroretentive gel formulations
Jagotec Ag
November 09, 2017 - N°20170319698

The present invention provides a gastric retentive gel composition comprising: (a) a hydrophobic or amphiphilic liquid gelled with an organogelator; (b) an active agent; and (c) a hard wax or wax-like additive, for controlled delivery of the active agent to or through the upper gastrointestinal tract, in particular to or through the stomach. The gel composition forms a stable, floating ...
Gastrointestinal Patent Pack
Download 314+ patent application PDFs
Gastrointestinal Patent Applications
Download 314+ Gastrointestinal-related PDFs
For professional research & prior art discovery
inventor
  • 314+ full patent PDF documents of Gastrointestinal-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Media supplements and methods to culture human gastrointestinal anaerobic microorganisms
University Of Guelph
November 09, 2017 - N°20170319633

A media supplement for culturing anaerobic bacteria is provided which comprises a filtrate of effluent from a chemostat vessel in which a target bacterial ecosystem has been cultured. Methods of using the supplement for culturing or isolating anaerobic microbial strains or communities, particularly anaerobic bacteria from the human gut, are also provided.
Systems and methods for producing gastrointestinal tissues at an anstomosis or other physiological location
Biostage, Inc.
November 09, 2017 - N°20170319325

Aspects of the disclosure relate methods and synthetic scaffolds for regenerating gastrointestinal tissue (e. G., esophageal tissue).
Serum-based mirna microarray and its use in diagnosis and treatment of barrett's esophagus (be) and ...
Biostage, Inc.
November 02, 2017 - N°20170314080

Robust and reliable molecular diagnostic screening tools for early detection of esophageal and gastrointestinal tract cancers and pre-cancerous lesions, such as barrett's esophagus, and esophageal adenocarcinoma are provided. Included in the invention is an array of mirna probes specific for identifying, diagnosing and prognosticating esophageal and gastrointestinal tract cancers and pre-cancerous lesions in subjects from blood or serum samples. A ...
Gastrointestinal Patent Pack
Download 314+ patent application PDFs
Gastrointestinal Patent Applications
Download 314+ Gastrointestinal-related PDFs
For professional research & prior art discovery
inventor
  • 314+ full patent PDF documents of Gastrointestinal-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
Biostage, Inc.
November 02, 2017 - N°20170312336

A method of treating a patient who has gastric cancer includes administering to said patient a composition containing a population of activated t cells that selectively recognize cells in the patient that aberrantly express a peptide. A pharmaceutical composition contains activated t cells that selectively recognize cells in a patient that aberrantly express a peptide, and a pharmaceutically acceptable carrier, ...
Antibacterial and protective formulations and methods for making and using them
Biostage, Inc.
November 02, 2017 - N°20170312322

Provided are compositions and methods for treating, ameliorating and preventing various infections, disorders and conditions in mammals, including genetically-predisposed and chronic disorders, where a microbial or bacterial flora is at least one causative or symptom-producing factor, where exemplary compositions are products of manufacture, a food, a drink, a nutraceutical, a dietary supplement, a formulation, a pharmaceutical or a pharmaceutical preparation ...
Pyrimidine compounds as jak kinase inhibitors
Biostage, Inc.
November 02, 2017 - N°20170312280

Wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of jak kinases. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat gastrointestinal and other inflammatory diseases, and processes and intermediates useful for preparing such compounds.
New indication of azelnidipine pharmaceutical composition for treating cancer
Biostage, Inc.
November 02, 2017 - N°20170312260

A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of azelnidipine or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of a pleural-related cancer, an abdominal-related cancer, an endocrine-related cancer, a gastrointestinal tract-related cancer, osteosarcoma, and skin cancer.
Anchorless intragastric device for treating obesity
Biostage, Inc.
November 02, 2017 - N°20170312111

A intragastric device that contains a compressible free-floating structure and a sleeve attached thereto is provided. The device is considered to be anchorless as the sleeve is not physically attached to any portion of the gi tract. The device is configurable between a compressed pre-deployment configuration and an expanded post-deployment configuration. The free-floating device may be composed of a shape ...
Nerve stimulation and blocking for treatment of gastrointestinal disorders
Enteromedics Inc.
October 26, 2017 - N°20170304615

At least one of a plurality of gastrointestinal disorders is treated by stimulating an enteric nervous system of a patient to enhance a functional tone of the enteric nervous system. A treatment includes electrically stimulating a vagus nerve of the patient at a stimulation site proximal to at least one site of vagal innervation of a gastrointestinal organ. The electrical ...
Novel immunotherapy against several tumors including gastrointestinal and gastric cancer
Immatics Biotechnologies Gmbh
October 26, 2017 - N°20170304399

A pharmaceutical composition contains an antibody or a fragment thereof specific for col6a3 for the treatment of a cancer. A method of treating a cancer includes administering to a subject in need thereof the pharmaceutical composition. A kit includes a container that contains the pharmaceutical composition. A method of producing an antibody or a fragment thereof against a peptide ...
Gastrointestinal Patent Pack
Download 314+ patent application PDFs
Gastrointestinal Patent Applications
Download 314+ Gastrointestinal-related PDFs
For professional research & prior art discovery
inventor
  • 314+ full patent PDF documents of Gastrointestinal-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Capsule for the oral administration of biopharmaceuticals
Symbiotic Health Inc.
October 26, 2017 - N°20170304374

In one embodiment the invention provides a capsule for the oral administration of biopharmaceuticals to the gastrointestinal system. The capsule includes a capsule shell enveloping a lipophilic matrix permeated with discrete microcapsules. Each microcapsule is a hydrophilic matrix formed of an internal phase comprising an aqueous medium, stabilized into a discrete structure by a colloidal polymer, and containing the biopharmaceutical(...
New indication of paroxetine pharmaceutical composition for treating cancer
Launx Biomedical Co., Ltd.
October 26, 2017 - N°20170304286

A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of paroxetine or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of pleural-related cancer, abdominal-related cancer, endocrine-related cancer, gastrointestinal tract-related cancer, osteosarcoma, skin cancer, and blood cancer. The pleural-related cancer is lung cancer. ...
New indication of cinacalcet hcl pharmaceutical composition for treating cancer
Launx Biomedical Co., Ltd.
October 26, 2017 - N°20170304228

A method for treating a cancer includes administering to a subject in need thereof a pharmaceutical composition containing a therapeutically effective amount of cinacalcet hcl or a pharmaceutical acceptable salt thereof. The cancer is selected from the group consisting of a pleural-related cancer, an abdominal-related cancer, an endocrine-related cancer, a gastrointestinal tract-related cancer, osteosarcoma, skin cancer, and blood cancer.
New indication of monobenzone pharmaceutical composition for treating cancer
Launx Biomedical Co., Ltd.
October 26, 2017 - N°20170304218

A method for treating a cancer includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition comprising monobenzone or a pharmaceutical acceptable salt thereof. The cancer is selected from pleural-related cancer, abdominal-related cancer, endocrine-related cancer, gastrointestinal tract-related cancer, osteosarcoma, and skin cancer. The pleural-related cancer is lung cancer. The abdominal-related cancer is selected from ...
Controlled release and taste masking oral pharmaceutical composition
Cosmo Technologies Limited
October 26, 2017 - N°20170304209

Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i. E. A structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices. The use of a plurality of systems for the control of the dissolution of the active ingredient modulates the dissolution rate of ...
Ph dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and ...
Plx Opco Inc.
October 26, 2017 - N°20170304190

Novel drug carriers capable of targeted and/or ph dependent release of biologically active agents into selected ph environments including the gastrointestinal (gi), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (ffa) are able to deliver biologically active agents to various ph environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious ...
Gastrointestinal device
Lean Medical Technologies, Llc
October 26, 2017 - N°20170304101

A gastrointestinal device and method for retrieving the device are disclosed. The device may include a stent including a plurality of strands forming first and second ends, the strands configured to move between a retrieval configuration, with substantially parallel strands, and a deployed configuration, wherein the strands form proximal and distal portions having first and second diameters larger than the ...
Origami robots, systems, and methods of treatment
Children's Medical Center Corporation
October 26, 2017 - N°20170303965

Origami robots, and associated systems, methods of treatment, and methods of manufacture are provided. A system includes an origami robot encapsulated for ingestion by a patient, such as in a biocompatible material that is dissolvable or meltable within the gastrointestinal tract. A method of treatment includes delivering an origami robot in a folded position into a gastrointestinal tract of a ...
Loading